Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
22.30
-0.04 (-0.18%)
At close: Sep 11, 2026, 4:00 PM EDT
23.11
+0.81 (3.63%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $1.32 billion as of September 11, 2026. Its market cap has increased by 478.57% in one year.
Market Cap
1.32B
Enterprise Value
856.07M
1-Year Change
478.57%
Ranking
Category
Stock Price
$22.30
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has increased from $1.30B to $1.32B, an increase of 1.56%. That is a compound annual growth rate of 0.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.32B | 160.50% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 1.37B |
| Savara | 1.35B |
| Alpha Tau Medical | 1.33B |
| Cullinan Therapeutics | 1.33B |
| Omeros | 1.32B |
| Tyra Biosciences | 1.31B |
| First Tracks Biotherapeutics | 1.30B |
| Aktis Oncology | 1.30B |